Atlas Trials

Neuroprotective Effect of (Nano PSO), in Patients Who Used to Consume Psychoactive Substances

Clinical trial NCT06550167 · RECRUITING

Trial details

NCT number
NCT06550167
Sponsor
Distribuidora Biolife SA de CV
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Addiction;Drug(S);LSDNeuroprotective
Start date
2024-03-15
Primary completion
2026-03-30
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.